The US Senate Committee on Health, Education, Labor and Pensions advanced the FDA Safety and Landmark Advancements (FDASLA) Act on 14 June with barely a mention of provisions to dramatically overhaul federal cosmetics regulations.
However, one voice emerged from the markup as a potential cosmetics industry ally. In his opening remarks, ranking member Richard Burr, R-NC, who introduced S. 4348 along with Sen....
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?